Repository logo
 

SARS-CoV-2 within-host diversity and transmission.

Published version
Peer-reviewed

Type

Article

Change log

Authors

de Cesare, Mariateresa  ORCID logo  https://orcid.org/0000-0002-9847-1526
MacIntyre-Cockett, George 

Abstract

Extensive global sampling and sequencing of the pandemic virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have enabled researchers to monitor its spread and to identify concerning new variants. Two important determinants of variant spread are how frequently they arise within individuals and how likely they are to be transmitted. To characterize within-host diversity and transmission, we deep-sequenced 1313 clinical samples from the United Kingdom. SARS-CoV-2 infections are characterized by low levels of within-host diversity when viral loads are high and by a narrow bottleneck at transmission. Most variants are either lost or occasionally fixed at the point of transmission, with minimal persistence of shared diversity, patterns that are readily observable on the phylogenetic tree. Our results suggest that transmission-enhancing and/or immune-escape SARS-CoV-2 variants are likely to arise infrequently but could spread rapidly if successfully transmitted.

Description

Keywords

COVID-19, Coinfection, Coronavirus Infections, Coronavirus OC43, Human, Family Characteristics, Genetic Variation, Genome, Viral, Humans, Immune Evasion, Mutation, Phylogeny, RNA, Viral, RNA-Seq, SARS-CoV-2, Selection, Genetic, Spike Glycoprotein, Coronavirus, United Kingdom, Viral Load

Journal Title

Science

Conference Name

Journal ISSN

0036-8075
1095-9203

Volume Title

372

Publisher

American Association for the Advancement of Science (AAAS)
Sponsorship
MRC (MC_PC_19027)
UK Research and Innovation (MC_PC_19027)
We gratefully acknowledge the UK COVID-19 Genomics Consortium (COG UK) for funding. COG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR), and Genome Research Limited, operating as the Wellcome Sanger Institute.